Floatz logo

13 assets in Ovarian Disorder

Therapeutic assets addressing Ovarian Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Irinotecan
Ovarian Disorder
Xiaoxiang ChenP3BB (70)
Adriamycin
Ovarian Disorder
Innovent Biologics (Suzhou) Co. Ltd.P3BB (68)
Carboplatin
Ovarian Disorder
Fujian Cancer HospitalP3BB (68)
Olaparib
Ovarian Disorder
Xiaoxiang ChenP2BB (64)
ibi354
Ovarian Disorder
Innovent Biologics (Suzhou) Co. Ltd.P3B (60)
Pembrolizumab
Ovarian Disorder
Sheba Medical CenterP2B (60)
Adebrelimab
Ovarian Disorder
Fujian Cancer HospitalP2CCC (53)
Catequentinib
Ovarian Disorder
Wenjun ChengP2CCC (53)
Fuzuloparib
Ovarian Disorder
Fujian Cancer HospitalP2CCC (53)
Lenvatinib
Ovarian Disorder
Sheba Medical CenterP2CCC (53)
Durvalumab
Ovarian Disorder
AstraZenecaP1/2CCC (48)
Pasifolate Exatecan
Ovarian Disorder
Elucida OncologyP1/2CCC (48)
ab-1015
Ovarian Disorder
Arsenal Biosciences, Inc.P1CC (43)